Search

Displaying results 9141 - 9150 of 10000 in total
  1. Drug

    Nagrestipen

    go.drugbank.com/drugs/DB12075
    Investigational

    Nagrestipen has been used in trials studying the treatment of CANCER, Neoplasm, Metastasis, Radiation Oncology, and Neoplasm Metastasis.

  2. Drug

    Enobosarm

    go.drugbank.com/drugs/DB12078
    Investigational

    Enobosarm has been used in trials studying the treatment of Stress Urinary Incontinence and Triple Negative Breast Cancer.

  3. Drug

    BMS-275183

    go.drugbank.com/drugs/DB12144
    Investigational

    BMS-275183 has been used in trials studying the treatment of Tumors and Non-small Cell Lung Cancer.

  4. Drug

    Veledimex

    go.drugbank.com/drugs/DB12170
    Investigational

    Veledimex has been used in trials studying the treatment of Glioblastoma Multiforme, Metastatic Breast Cancer, and Anaplastic Oligoastrocytoma.

  5. Drug

    Atamestane

    go.drugbank.com/drugs/DB12194
    Investigational

    Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.

  6. Drug

    GSK-424887

    go.drugbank.com/drugs/DB12219
    Investigational

    Gsk424887 has been used in trials studying the basic science and treatment of Depressive Disorder and Anxiety Disorder.

  7. Drug

    MK-0777

    go.drugbank.com/drugs/DB12238
    Investigational

    MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized Anxiety Disorder.

  8. Drug

    CP-724714

    go.drugbank.com/drugs/DB12302
    Investigational

    CP-724,714 has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasm Metastasis.

  9. Drug

    Nepadutant

    go.drugbank.com/drugs/DB12538
    Investigational

    Nepadutant has been used in trials studying the treatment of Colic, Infantile Colic, and Infantile Functional Gastrointestinal Disorders.

  10. Drug

    IC41

    go.drugbank.com/drugs/DB05776
    Investigational

    IC41 is a therapeutic peptide vaccine. It is being devloped by Intercell AG for the treatment of hepatitis C. The vaccine consists of five synthetic peptides (IPEP83, 84, 87, 89,1426) harboring HCV CD4 and CD8 T-cell epitopes and the syn...